Latest Markets Business BEEPS Earnings Personal Finance

Dr Reddy's Introduces Generic Medication For Bacterial Infections In US

Dr Reddy's Laboratories introduces generic medication for bacterial infections in the US market with the launch of Doxycycline Capsules (40 mg).

PTI

Picture for representation (Source: Dr Reddy's Laboratories/X)

Dr Reddy's Laboratories on Friday said it has launched a generic medication, used to treat a wide variety of bacterial infections, in the US market.

The company has launched Doxycycline Capsules (40 mg) in the US market, the Hyderabad-based drug maker said in a statement.

The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration.

Shares of the company on Friday ended 0.71% up at Rs 6,332.85 apiece on the BSE.

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google
Beeps Img

Metal Stocks Glitter As JSW Steel, Tata Steel Hit New Peaks. Can The Shine Last?

  • chevron-double-right JSW Steel and Tata Steel hit 52-week highs amid firm demand and supply limits in China
  • chevron-double-right China's steel output cuts and India's extended safeguard duty support local producers
  • chevron-double-right Brokerages remain bullish, raising target prices on JSW Steel and Jindal Steel and Power
More Beeps chevron-right

RECOMMENDED FOR YOU

India's Largest REIT Plans $181 Million Debut Rupee Bond Sale
timelogo Sep 22, 2025
JPMorgan Sees India As ‘Bright Spot’ Despite Trump Tariff Woes
timelogo Sep 22, 2025
Voltas Eyes Sequential Recovery Amid Market Challenges; Nirmal Bang Maintains 'Hold', Revises Target Price 
timelogo Sep 22, 2025
Nuvoco Vistas Gets Systematix 'Buy' Call As In Initiates Coverage
timelogo Sep 22, 2025

POPULAR

1
I'm Waiting In The Street: French President Macron Tells Donald Trump | Watch Video
2
Tax Treatment Under UPS: Top 10 FAQs Answered — All You Need To Know
3
Responsible AI In Finance: Principles, Pillars, Pathways For India's Future
4
Hexagon Nutrition Files Draft Papers With SEBI For IPO
5
FPIs Stay Net Sellers For Second Consecutive Session